Previous 10 | Next 10 |
Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences Jefferies London Healthcare Conference 4th Annual Evercore ISI HealthCONx Conference PR Newswire DUBLIN , Nov. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JA...
Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings Guidance PR Newswire DUBLIN , Nov. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 20...
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual Meeting Sixteen new abstracts to be presented, including the first presentation of data from the Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) ...
Jazz has announced the launch of its latest drug, Xywav: the first and only treatment option for idiopathic hypersomnia, with the potential for further indications in future. It has recently completed the acquisition of GW Pharmaceuticals and its portfolio of cannabis derived drugs, s...
FT218 PDUFA was delayed by the FDA, reasons unknown, suspected staffing issues at the agency. FT218 has a clear advantage over Xyrem. I am holding tight. For further details see: Avadel Pharmaceuticals: I Am Holding
After a tough September when the S&P 500 fell by 4.8%, the markets have been showing strength again with the index rising more than 5% in October. But many quality stocks haven't been rising of late, and there are a couple of gems out there that investors may want to buy for Novembe...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Identifying stocks to buy on the dip will always be a winning strategy for long-term investors. So you should always keep some companies on the radar to get long when stock prices become more attractive. Therefore, today...
Jazz Pharmaceuticals to Report 2021 Third Quarter Financial Results on November 9, 2021 PR Newswire DUBLIN , Oct. 26, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 third quarter financial results on ...
After last week’s move to nearly US$1,800 per ounce , this week brought ups and downs for gold. The yellow metal moved between about US$1,760 and US$1,790 during the period, and was around US$1,790 at the time of this writing on Friday (October 22) afternoon. ...
A US House Committee on 30th September passed a bill that could legalize marijuana. The bill seeks to decriminalise and deschedule cannabis, putting it in the same category as nicotine. As a result, the cannabis industry could experience significant growth, thus boosting stock p...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance PR Newswire – 15% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – O...
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting PR Newswire Ms. Hamill brings extensive experience and proven leadership focused on commercial growth and shareholder value DUBLIN , July 25, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals In celebration of Pride Month , we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for unders...